DNA Testing Market Analysis By Technology, Application And segment Forecast Up To 2022

Global DNA Testing Market is anticipated to reach USD 10.04 billion by 2022, according to a new study by Grand View Research Inc. Rise in developments in the field of genome sequencing and personalized DNA level diagnostic applications, a considerable growth in the number of patented research initiatives by the government and government funded projects are factors expected to drive demand during the forecast period.

Introduction of novel technologies for genome profiling are expected to boost progress of this industry over the forecast period. Furthermore, increasing incidences of chronic oncology and infectious diseases that depend on DNA prototyping for treatment and diagnosis using personalized medicine are anticipated to significantly raise demand for DNA diagnostics/testing based research thereby propelling industrial growth in the coming years. Increasing demand for prenatal testing and in-vitro fertilization that subsequently leads to rise in demand for DNA diagnostics/testing is also attributive towards expected progress in this market.

Full Research Report on Global DNA Testing Market Analysis: http://www.grandviewresearch.com/industry-analysis/dna-testing-market

Further key findings from the study suggest:

• PCR based diagnosis accounted for the largest share of the market revenue in 2014 as a result of higher preference rate coupled with higher availability of products and reagent kits of this segment.
• Next generation sequencing application for DNA testing is estimated to witness significant progress with a double digit CAGR of over 16% amongst the other technology segments due to presence of significant advantages offered by this technique of DNA identification and testing.
• Infectious disease diagnostics accounted for the largest market share in 2014 due to higher incidence rate of various infectious disorders which subsequently raises the demand for in-vitro nucleic acid based diagnostic tests for diagnosis and monitoring of disease progression.
• There are diverse applications of DNA testing market out of which oncology diagnostics and histopathology is estimated to register lucrative growth over the forecast period. Factors attributing for considerable growth potential in this segment include identification of cancer causing genes & associated research, and facilitation in mutation detection
• North America dominated the market in 2014, with revenue estimated at over USD 2,600 million. Presence of sophisticated healthcare infrastructure, rising incidence of genetic abnormalities, favorable government initiatives with respect to genetic diagnosis and its application in in-vitro fertilization are major factors driving growth of this region.
• Asia Pacific is anticipated to witness lucrative growth as a result of developments in health care infrastructure in this region coupled with presence of significant number of target population that is suffering with chronic as well as acute disorders. Government initiatives taken up herein are also attributive to influence sector growth to a great extent.
• Key participants of DNA testing industry include Abbott Laboratories, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Applied Biosystems Group, Cepheid Inc., Transgenomic Inc., Siemens Healthcare, Roche Diagnostics, Qiagen, Illumina, GE Healthcare, Alere Inc, Affymetrix Inc., Hologic, Dako, and 454 Life Sciences.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented DNA Testing Market on the basis of technology, application, and region:

 Global DNA Diagnostics/Testing Technology Outlook (Revenue, USD Million, 2012 - 2022)

• Microarrays based diagnostics
• PCR based diagnostics
• In-situ hybridization diagnostics
• NGS DNA diagnosis

Global DNA Diagnostics/Testing Application Outlook (Revenue, USD Million, 2012 - 2022)

• Prenatal DNA Carrier Screening
• Preimplantation Diagnosis
• Newborn Genetic Screening
• Infectious Disease Diagnostics
• HBV Diagnostic
• HCV Diagnostic
• HIV Diagnostic
• TB Diagnostic
• CT/NG Diagnostic
• HPV Diagnostic
• MRSA Diagnostic
• Others
• Oncology Diagnostics & Histopathology
• Identity Diagnostics & Forensics
• Pharmacogenomics Diagnostic Testing
• Drug Metabolism & P450 effects
• Others

DNA Diagnostics/Testing Regional Outlook (Revenue, USD Million, 2012 - 2022)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Mexico
• MEA
• South Africa

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-dna-testing-market  

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Distributed Natural Gas-Fueled Generation Market Analysis By Technology, End-Use, And Segment Forecast Up To 2024

Global Distributed Natural Gas-Fueled Generation Market is expected to reach USD 32.21 Billion by 2024, according to a new report by Grand View Research, Inc. Increasing government initiatives to promote the use of natural gas as a generator fuel especially in emerging markets of China, and India is expected to boost the global market.  In addition, various benefits offered by DNGG, such as low carbon emissions, increasing natural gas usage, and other operational benefits,  are expected to steer the market growth over the forecast period.

There are huge investments in the power sector to develop the distributed generation technologies by emerging companies. At the same time, they are in need of high technologies, which will act as a substitute for current methods like diesel or coal generation.

The companies R&D facilities of hydrogen and fuel cell focuses on integrating, developing, and demonstrating hydrogen storage, delivery and production and also on using fuel cell technologies for stationary, transportation, and portable applications to differentiate their product from their competitor.

Full Research Report on Global Distributed Natural Gas-Fueled Generation Market Analysis:
http://www.grandviewresearch.com/industry-analysis/distributed-natural-gas-fueled-generation-market

Further key findings from the report suggest:

• Stationary fuel cells hold the largest CAGR of 13.1% in the global technology segment and are expected to grow at 6,116.8 million by 2024.
• Microturbines technology in Europe is estimated to be USD 3,964.8 million in 2015 and will witness the fastest growth in next seven years, growing at a CAGR of 12.2% over the forecast period. By integrating an innovating turbine engine, advanced power electronics, magnetic generator with fuel cell technology, the micro turbine can provide cleaner energy which will increase the DNGG market.
• Commercial and industrial accounted for around 67% of the global DNGG end-use segment in 2015 and is anticipated to reach 20,620.1 million by 2024, growing at an anticipated CAGR of 12% from 2016 to 2024.
• Europe accounted for 36% of the total market in 2015 and is anticipated to hold its leading position over the forecast period. Asia Pacific is anticipated to witness a high CAGR of over 13.1% over the forecast period. Increasing usage of DNGG in residential and commercial sector coupled with government initiatives mainly in China and India is expected to boost DNGG demand in the region.
• Key industry participants in the market includeCummins Inc., ShanDongLvhuan Power Equipment CO., LTD, MWM GmbH, ABB Group, Redox Power Systems, LLC, General Electric, and Plug Power Inc.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/construction-and-utilities

Grand View Research has segmented the Global Natural Gas-Fueled Generation Market on the basis of technology, end-use and region:

Global Distributed Natural Gas-Fueled Generation Technology Outlook (Revenue, USD Million, 2014 - 2024)

• Natural Gas Gensets
• Stationary fuel cells
• Microturbines

Global Distributed Natural Gas-Fueled Generation End-Use Outlook (Revenue, USD Million, 2014 - 2024)

• Residential
• Building & institutional
• Commercial & industrial

Global Distributed Natural Gas-Fueled Generation Regional Outlook (Revenue, USD Million, 2014 - 2024)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• Asia Pacific
• China
• India
• Central & South America
• Middle East & Africa

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-distributed-natural-gas-fueled-generation-market

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Peptide Therapeutics Market Is Expected To Grow At CAGR Of 9.4% Over The Forecast Period 2014-2025

Global Peptide Therapeutics Market is expected to reach USD 48.04 billion by 2025, according to a new report by Grand View Research, Inc. Increasing demand for efficient & rapid-acting therapeutics for treatment of cancer and other lifestyle-associated disorders, which result in lesser adverse effects, are anticipated to propel market growth. 

Rising incidence of cancer calls for exploring and introducing other means of therapies and low-cost treatment alternatives. Moreover, growing base of geriatric population is expected to widen the consumer base by triggering incidence rate of target diseases such as cancer & diabetes, which are expected to drive the demand for peptide therapeutics.

Technological advancements in peptide manufacturing process is one of the major factors driving the market growth during the forecast period. Manufacturers and suppliers are focusing on the adoption of novel technologies to manufacture efficient drug molecules with low time and capital investment. Improvement in purification & automation process and less generation of waste is an additional factor attributing toward market growth

Full Research Report on Global Peptide Therapeutics Market Analysis:
http://www.grandviewresearch.com/industry-analysis/peptide-therapeutics-market

Further Key Findings From the Study Suggest:

• Cancer held the largest market share in 2016 owing to increasing demand for alternative therapeutics over conventional treatment options. Peptides are being used as potential therapeutic agents in cancer treatment.
• The generic drug segment is expected to showcase upward shift due to patent expiration of blockbuster peptides and supportive government initiatives pertaining to the introduction of generic class
• Outsourced manufacturing is expected to grow at CAGR of 6.7% owing to requirements of complex procedures and shift in preference toward outsourcing, which helps in eliminating cost of production.
• Route of administration including nasal and intradermal routes is expected to grow at a rapid pace owing to ease of usage and advantages over other routes of administration such as oral.
• Hybrid technology is expected to spearhead the growth of this market. Benefits associated with this technology such as time conservation and ease of usage for both solid- and liquid-phase peptide synthesis are the key factors affirming growth.
• North America held the largest share in terms of revenue in 2016 owing to higher level of awareness pertaining to genomics & proteomics products, well-established R&D infrastructure, and rising funding initiatives
• Asia Pacific industry is expected to showcase lucrative growth over the forecast period with CAGR of 11.0%. Presence of established generic industry and API providers in this region coupled with growing economic stability in some of the countries is expected to propel market growth.
• Some of the key players in the peptide therapeutics market include Eli Lilly and Company; Pfizer, Inc.; Amgen, Inc.; Takeda Pharmaceutical Company Limited; Teva Pharmaceuticals Industries Ltd.; Lonza Inc.; Sanofi; Bristol-Myers Squibb (BMS); AstraZeneca PLC; GlaxoSmithKline plc (GSK); Novartis AG; and Novo Nordisk A/S

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Global Peptide Therapeutics Market by application, type, type of manufacturers, route of administration, synthesis technology, and region:

Peptide Therapeutics, Application Outlook (Revenue, USD Million; 2014 - 2025)

• Cancers
• Metabolic
• Cardiovascular Disorder
• Respiratory
• GIT
• Antiinfection
• Pain
• Dermatology
• CNS
• Renal
• Others

Peptide Therapeutics, Type Outlook (Revenue, USD Million; 2014 - 2025)

• Generic
• Innovative

Peptide Therapeutics, Type of Manufacturers Outlook (Revenue, USD Million; 2014 - 2025)

• In-house
• Outsourced

Peptide Therapeutics, Route of Administration Outlook (Revenue, USD Million; 2014 - 2025)

• Parenteral Route
• Oral Route
• Pulmonary
• Mucosal
• Others

Peptide Therapeutics, Synthesis Technology Outlook (Revenue, USD Million; 2014 - 2025)

• Solid Phase Peptide Synthesis (SPPS)
• Liquid Phase Peptide Synthesis (LPPS)
• Hybrid Technology

Peptide Therapeutics, Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• India
• Latin America
• Mexico
• Brazil
• MEA
• South Africa

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-peptide-therapeutics-market             

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Surgical Equipment Market Is Estimated To Growing At A CAGR Of 7.8% During Forecast Period 2014-2025

Global Surgical Instruments/Equipment Market is anticipated to reach a value of USD 20.3 billion by 2025, according to a new report by Grand View Research, Inc. Increasing number of minimally invasive surgeries across the globe is anticipated to accelerate the market growth.

Treatment of chronic diseases often require surgeries. Rising prevalence of chronic diseases, such as, cardiovascular and neurological disorders is adversely impacting the society. Surgery is considered as the primary mode of treatment for patients suffering from such diseases, thereby, giving rise to more number of surgical procedures being conducted. Minimally invasive surgeries are also highly adopted by surgeons for treating several heart disorders.

Road and other accidents are also anticipated to raise the demand for surgical instruments in the coming years. Accident is one of the leading causes of severe injuries. Based on statistics from Association for Safe International Road Travel, around 2.35 million people gets injured every year due to such accidents. As a result, there is a high demand for wound closure surgical procedures, which in turn is expected to raise the demand for surgical tools.

Full Research Report on Global Surgical Equipment Market Analysis:
http://www.grandviewresearch.com/industry-analysis/surgical-equipment-market

Further Key Findings From the Study Suggest: 

• The global surgical equipmentmarket $10.5 Billion in 2016 and is expected to grow at 7.8% CAGR from 2017 to 2025

• Surgical sutures and staplers held the largest market share in 2016 owing to its high cost and huge application in wound closure surgeries
• Electrosurgical equipment are anticipated to witness attractive growth over the forecast period due to growing trend towards minimally invasive surgeries
• Obstetrics and gynecology dominated the market in 2016 due to large number of caesarean surgeries being performed worldwide
• Plastic and reconstructive surgeries is expected to show lucrative CAGR in the coming years due to increasing concern for esthetics among women
• In 2016, North America dominated the market due to the availability of skilled surgeons and technologically advanced surgical tools in the U.S.
• Asia Pacific is expected to show fastest growth over the forecast period owing to the rising number of road accident cases in India
• Major companies operating in the market include Becton, Dickinson and Company; Stryker Corporation; B. Braun Melsungen AG; Zimmer Biomet Holdings, Inc.; Aspen Surgical Products, Inc.; Smith & Nephew plc; Medtronic; Alcon Laboratories, Inc.; and Ethicon, Inc.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Surgical Equipment/Instruments Market on the basis of product, application and region:

Surgical Equipment/Instruments Product Outlook (Revenue, USD Million; 2014 - 2025)

• Surgical Sutures and Staplers
• Handheld Surgical Devices
• Forceps and Spatulas
• Retractors
• Dilators
• Graspers
• Auxiliary Instruments
• Cutter Instruments
• Others
• Electrosurgical Devices

Surgical Equipment/Instruments Application Outlook (Revenue, USD Million; 2014 - 2025)

• Neurosurgery
• Plastic and Reconstructive Surgery
• Wound Closure
• Obstetrics and Gynecology
• Cardiovascular
• Orthopedic
• Others

Surgical Equipment/Instruments Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-surgical-equipment-market           

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Patient Temperature Management Market Report Covers Revenue Forecast, Company Share, Competitive Landscape, Growth Factors And Trends 2014-2025

Global Patient Temperature Management Market is anticipated to reach a value of USD 4.6 billion by 2025, according to a new report by Grand View Research, Inc. Rising number of surgeries is anticipated to accelerate the demand for temperature management devices. For instance, open heart surgeries require lowering down of patient’s body heat through blood cooling, which helps in reducing the risk of post and perioperative surgical complications. 

With growing prevalence of cardiac arrest and other chronic cardiac diseases, there is a rising number of surgeries being undertaken. Hence, this raises the need for patient temperature management, in order to avoid the adverse effects on brain. Patient warming systems are also used for cancer patients as adjuncts with chemotherapy and radiation therapy for more effective results. Moreover, in neonatal care, newborns are likely to experience temperature fluctuations and hence, they are kept in incubators to maintain their normal body temperature.  As a result, the aforementioned factors are giving rise to high demand for temperature monitoring devices.

Advancements in technology have also enhanced the product portfolio of temperature management devices.  For instance, 3M revolutionized its Bair Hugger brand, which includes a complete portfolio of blankets, such as underbody, full body, specialty, and others. The blood & fluid temperature management systems have also evolved with new technology, facilitating circulation of warm or cool saline with the help of a catheter to the patient’s body. Thus, rising technological advancements have led to high market growth.

Full Research Report on Global Patient Temperature Management Market Analysis:
http://www.grandviewresearch.com/industry-analysis/patient-temperature-management-market

Further Key Findings From the Study Suggest:

• Patient warming systems held the largest market share in 2016 due to high usage of these devices before surgery, when provided with general anesthesia
• Patient cooling systems are anticipated to exhibit lucrative CAGR over the forecast period due to the introduction of new products like cooling caps and blood & fluid cooling systems
• Surgery segment dominated the market share in 2016 due to increasing number of cardiac and gynecological surgeries across the globe
• In 2016, North America held the largest market share due to rising demand for technologically advanced products
• Asia Pacific is expected to show lucrative growth over the forecast period, due to increasing sedentary lifestyle resulting in cardiac related disorders
• Some of the major companies include Stryker Corporation; ZOLL Medical Corporation; Cincinnati Sub-Zero Products, LLC; Medtronic, Inc.; 3M Company; Bard Medical, Inc.; and The 37Company
• In 2014, Medtronic acquired Covidien plc with an aim to enter the temperature management business

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Patient Temperature Management Market on the basis of product, application, end use, and region:

Patient Temperature Management Product Outlook (Revenue, USD Million; 2014 - 2025)

• Patient Warming Systems
• Conventional Warming Systems
• Surface Warming Systems
• Intravascular Warming Systems
• Patient Cooling Systems
• Conventional Cooling Systems
• Surface Cooling Systems
• Intravascular Cooling Systems

Patient Temperature Management Application Outlook (Revenue, USD Million; 2014 - 2025)

• Surgery
• Cardiology
• Pediatrics
• Neurology
• Others

Patient Temperature Management End-Use Outlook (Revenue, USD Million; 2014 - 2025)

• Operating Room
• Neonatal ICU
• Emergency Room
• ICUs
• Others

Patient Temperature Management Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/blog/patient-temperature-management-market-size-trends           

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Electrodes For Medical Devices Market Is Expected To Grow At A CAGR Of 11.3% During The Forecast Period 2014-2025

Global Electrodes For Medical Devices Market is expected to reach USD 2.0 billion by 2025, according to a new report by Grand View Research, Inc. The market is anticipated to witness lucrative growth during the forecast period, owing to increasing prevalence of chronic and other diseases such as heart diseases, Parkinson’s Disease (PD), Alzheimer’s disease, brain disorders, Trigeminal Neuralgia (TN or TGN), sinusitis, tinnitus, Raynaud's disease, fibromyalgia, circulatory disturbances, gout, and body ache, across the globe. 

Minimally Invasive Surgery (MIS) is one of the advancements in medical technology in which small incisions are made in the body for laparoscopy, endoscopy, arthroscopy, and other surgical procedures. This procedure is gaining popularity owing to faster recovery, lesser postsurgical infections, pain, & major bleeding, reduced scarring, and high accuracy benefits. In 2015, over 20.0 million Americans underwent MIS, which is expected to assist in the growth of this vertical during the forecast period.

Full Research Report on Global Electrodes For Medical Devices Market Analysis: http://www.grandviewresearch.com/industry-analysis/electrodes-medical-devices-market

Further Key Findings From the Study Suggest:

• The diagnostic segment held a profitable revenue share in 2016 and is expected to grow at a significant rate over the forecast period.
• Rising prevalence of heart diseases, fetal distress syndrome, ocular diseases, and neurological disorders make extensive use of Electrocardiogram (ECG), Electroencephalogram (EEG), electrosurgical, and fetal scalp electrodes
• The therapeutic segment is anticipated to witness the fastest growth over the forecast period due to widened use of medical electrodes in aesthetic surgeries, RF ablation procedures, neurosurgical procedures, and acute & chronic pain treatments
• Defibrillator and electrosurgical electrodes are projected to hold substantial market share over the forecast period. This can be attributed to the advanced development of wearable defibrillator that constantly monitors the cardiac rhythms of the wearer and identifies & notifies the user about the occurrence of any abnormality and helps regain the normal heart functionality
• North America is expected to dominate the medical electrodes market during the forecast period, owing to the rising prevalence of CVDs, changing lifestyle of individuals, and presence of target population in the U.S. and Canada. In addition, the presence of advanced technologies with electrodes such as hydrogel and dry electrodes in the region are expected to spur the medical electrodes market growth.
• Some of the key players in medical electrodes market are 3M Healthcare; Boston Scientific Corporation; GE Healthcare; C.R Bard Inc.; CONMED Corporation; Medtronic; Natus Medical Incorporated; Thermo Fisher Scientific Inc.; Asahi Kasei Corporation; and Philips Healthcare

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Electrodes For Medical Devices Market on the basis of type and region:

Electrodes For Medical Devices Type Outlook (Revenue, USD Million, 2014 - 2025)

• Diagnostics
• Electrocardiogram (ECG)
• Electroencephalogram (EEG)
• Electromyogram (EMG)
• Electroretinogram (ERG)
• Fetal Scalp
• Other
• Therapeutics
• Pacemaker
• Transcutaneous Electrical Nerve Stimulator (TENS)
• Defibrillator
• Electrosurgical
• Other

Electrodes For Medical Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Mexico
• Middle East and Africa (MEA)
• South Africa

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-electrodes-medical-devices-market          

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com

eClinical Solutions Market Is Segmented On the Basis Of End-User Application And Region 2013-2024

eClinical Solutions Market is expected to reach USD 10.5 billion by 2024, according to a new report published by Grand View Research Inc. The eClinical solutions market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors attributing towards the growth of the market are increase in the research and development activities by numerous biopharma and pharma companies, increasing application of software solutions in clinical trials, upsurge in the government funding to promote clinical research programs, rise in the number of Contract Research Organizations (CROs) and life sciences organizations, and increasing customer base. 

Additionally, factors such as increasing outsourcing of clinical trials to CROs, escalating clinical research programs in Asian countries, as well as, the development of cost-effective modules are expected to be opportunistic for the industry growth. However, the shortage of skilled labor force, high implementation costs of the eClinical solutions and the lack of awareness of clinical data sciences software in the research community are likely to hinder the growth of the market in the near future. 

The eClinical solutions market is segmented on the basis of product, delivery mode, clinical trial phase, end-user, and region. Based on the product, the industry is categorized into clinical analytics platforms, electronic Clinical Outcome Assessment (eCOA), Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), clinical data integration platforms, safety solutions, Clinical Trial Management Systems (CTMS), Randomization and Trial Supply Management (RTSM), and electronic Trial Master File (eTMF). 

The other segments of the market include delivery mode (web-hosted, licensed enterprise, and cloud-based), clinical trial phases (phase I, phase II, phase III, and phase IV), and end-user application (consulting service companies, medical device manufacturers, hospitals, contract research organizations, pharmaceutical, and biopharmaceutical companies). On the basis of regions, the market is categorized into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa).

Full Research Report on Global eClinical Solutions Market Analysis:  http://www.grandviewresearch.com/industry-analysis/eclinical-solutions-market

Further key findings from the study suggest:

• In 2016, North America is estimated to lead the market with the largest share in the eClinical solutions industry. The rising number of ongoing clinical trials, high demand for technologically advanced products, and increasing financial support from the government is anticipated to boost the industry growth.
• The eCOA segment is anticipated to witness the highest growth rate during the forecast period, whereas the EDC and CDMS segment is estimated to lead the market in the year 2016. Factors attributing to the growth of the industry are the increasing application of mobile and digital technologies, as well as, an upsurge in the demand for eDiaries in clinical trials for the collection of patient’s self-reports by pharmaceutical companies.
• The eClinical solutions industry comprises several local as well as global players. Some of the major players in this industry include Oracle Corporation, Medidata Solutions Inc., Parexel International, Inc., and Datatrak, among others. 

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the Global eClinical Solutions Market on the basis of end-user application and region:

eClinical Solutions Product Outlook (Revenue, USD Million, 2013 - 2024)

• Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS) 
• Clinical Trial Management Systems (CTMS)
• Clinical Analytics Platforms
• Randomization and Trial Supply Management (RTSM) 
• Clinical Data Integration Platforms
• Electronic Clinical Outcome Assessment (eCOA)
• Safety Solutions
• Electronic Trial Master File (eTMF) 

eClinical Solutions Delivery Mode Outlook (Revenue, USD Million, 2013 - 2024)

• Web-hosted (On-demand)
• Licensed Enterprise (On-premise)
• Cloud-based 

eClinical Solutions Delivery Mode Outlook (Revenue, USD Million, 2013 - 2024)

• Consulting Service Companies
• Medical Device Manufactures
• Hospitals
• CROs
• Pharmaceutical Biopharmaceutical Companies 

eClinical Solutions Clinical Trial Outlook (Revenue, USD Million, 2013 - 2024)

• Phase I
• Phase II
• Phase III
• Phase IV 

eClinical Solutions Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-eclinical-solutions-market   
About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com